Speaker Profile
M.D., M.P.H., Medical Director, Cancer Commons
Biography
Dr. Brandman is a strategic innovator who works across multiple healthcare sectors. She is currently leveraging her deep experience across multiple healthcare sectors to launch a new AI-driven digital platform that provides integration and data services, persona driven processes, and automation to hospitals and their communities with a goal of enabling frictionless care in-home, in the community. Central to everything she does is her vision for patient-centric healthcare and empowering consumers to manage their own healthcare. Her journey began as an internist and includes founding a non-profit charity, Compassionate Access, to improve access to early-stage therapies for patients in need, as well as co-founding two companies focused on advancing early-stage science in cancer and anti-aging.Specialty skills: Telemedicine and virtual primary care, ACOs, product strategies, HIT and mobile health, AI and distributed systems, clinical process improvement, next-generation care delivery, and patient engagement.
Talk
Precision Medicine Access via Learning Health Platform N-of-1 Trials
Science outpaces FDA approval of new treatments. Expanded access doesnt scale. Focusing on patients, combining direct care and research, personalized care, and continuously harvesting data drives a continuous loop of knowledge generation, dissemination, and uptake for populations and individuals. Intro to what is needed to run n-of-1 trials: CRO-Lite services and a Learning Health System.
Clinical & Research Tools Showcase:
Cancer Commons
Cancer Commons is a non-profit network of patients, scientists, and physicians united by a shared goal—to optimize each patient’s outcome and maximize collective learning to benefit the next patient.
Session Abstract – PMWC 2025 Silicon Valley
The PMWC 2025 Clinical & Research Tools Showcase will provide a 15-30 minute time slot for selected companies in this space. The Clinical & Research Tools is a showcase for innovative technologies that are used for the analysis of genetic variation and function, helping to advance breakthroughs in genetic health, rare disease conditions on individuals of all ages, complex diseases and cancer care. Next-generation sequencing (NGS) and microarray technologies empower rapidly evolving genomic revolution.
